fda compounding tirzepatide ban on compounded tirzepatide: Switch to name brand medications Minus one of its GLP-1

Gastroparesis with bezoar formation in patients treated with glucagon-like peptide-1 receptor agonists: potential relevance for bariatric and other gastric surgery, January 2023, Preda et al

FuturHealth invites individuals to start a weight loss journey that goes beyond mere weight reduction, aiming for a future filled with improved health, vitality, and overall happiness

The second major comparative trial recently landed in Gastroenterology TEM or ESD in Early Rectal Tumors: A Clinical & Cost-Effectiveness Analysis The MUCEM Study (Beyer-Berjot et al., Gastroenterology 2026) The largest comparison of TEM/TAMIS and ESD to date: 330 patients across 23 French expert centers, prospective multicenter design

With that in mind, lets take a closer look at both the common and less common side effects of GLP-1 medications, as well as practical management strategies to help mitigate any discomfort or complications

It's taught me how to stop overeating